Cover Image
市場調查報告書

巴西的糖尿病市場分析

Brazil Diabetes Market Report: 2017 - 2022

出版商 IMARC Services Pvt. Ltd. 商品編碼 359376
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
巴西的糖尿病市場分析 Brazil Diabetes Market Report: 2017 - 2022
出版日期: 2017年02月15日 內容資訊: 英文 51 Pages
簡介

本報告提供巴西國內的糖尿病市場相關分析,目前流行病學的情形 (患者人口,盛行率等) 和背景情況,主要的治療方法,相關市場 (治療藥等)的變化及預測,近幾年的市場主要動向,競爭環境等相關調查。

第1章 分析方法

第2章 摘要整理

第3章 糖尿病概要

  • 糖尿病是什麼?
  • 糖尿病的診斷、治療
  • 糖尿病的併發症

第4章 巴西的糖尿病市場推動因素

第5章 巴西國內的糖尿病的流行病學

  • 糖尿病的患者數和盛行率
  • 患者數和盛行率:各類型 (第一型、第二型糖尿病)
  • 患者數和盛行率:各地區
  • 患者數和盛行率:男女
  • 患者數和盛行率:各年齡層

第6章 巴西的糖尿病市場

  • 過去的市場趨勢
  • 市場未來展望
  • 各部門的市場明細
  • 巴西的口服抗糖尿病藥物市場
    • 過去的市場趨勢
    • 各級的市場明細
    • 主要企業的市場佔有率
    • 市場未來展望
  • 巴西的胰島素市場

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SRP00116GU

IMARC's new report "Brazil Diabetes Market Report: 2017 - 2022" provides an analytical and statistical insight into the Brazil diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Brazil. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Brazil diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Brazil diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Brazil diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Brazil
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Brazil
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Brazil
  • Historical, current and future prevalence of diabetes among males and females in Brazil
  • Historical, current and future prevalence of diabetes among various age groups in Brazil
  • Historical, current and future diagnosis rates for diabetes in Brazil
  • Historical, current and future drug treatment rates for diabetes in Brazil

Comprehensive situation analysis of the Brazil Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Brazil
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Brazil Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Brazil
  • Performance of key classes
  • Performance of key players
  • Market outlook

Table of Contents

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Brazil Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Brazil Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Forecast
  • 7.4 SWOT Analysis
    • 7.4.1 Strengths
    • 7.4.2 Weaknesses
    • 7.4.3 Opportunities
    • 7.4.4 Threats
  • 7.5 Value Chain Analysis
  • 7.6 Porter's Five Forces Analysis
    • 7.6.1 Overview
    • 7.6.2 Bargaining Power of Buyers
    • 7.6.3 Bargaining Power of Suppliers
    • 7.6.4 Degree of Competition
    • 7.6.5 Threat of New Entrants
    • 7.6.6 Threat of Substitutes
  • 7.7 Market Breakup by Segment
    • 7.7.1 Brazil Oral Antidiabetics Market
      • 7.7.1.1 Historical Market Trends
      • 7.7.1.2 Market Breakup by Class
      • 7.7.1.3 Market Shares of Key Players
      • 7.7.1.4 Market Forecast
    • 7.7.2 Brazil Insulin Market
      • 7.7.2.1 Historical Market Trends
      • 7.7.2.2 Market Breakup by Class
      • 7.7.2.3 Market Shares of Key Players
      • 7.7.2.4 Market Forecast
  • 7.8 Competitive Landscape
    • 7.8.1 Competitive Structure
    • 7.8.2 Profiles of Key Players

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2016 & 2035
  • Figure 4: Brazil: Overweight & Obese Population* (in Million), 2010, 2016 & 2022
  • Figure 5: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 6: Brazil: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
  • Figure 7: Brazil: Diabetes Prevalence By Age Groups, (in %)
  • Figure 8: Brazil: Total Number of Diabetes Patients* (in 000), 2009-2016
  • Figure 9: Brazil: Total Number of Diabetes Patients* Forecast (in 000), 2017-2022
  • Figure 10: Brazil (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2009- 2016
  • Figure 11: Brazil (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2017-2022
  • Figure 12: Brazil (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2009 -2022
  • Figure 13: Brazil (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2017 - 2022
  • Figure 14: Brazil (Male & Female): Total Number of Diabetes Patients* (in 000), 2009 - 2016
  • Figure 15: Brazil (Male & Female): Total Number of Diabetes Patients* (in 000), 2017 - 2022
  • Figure 16: Brazil: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2009 - 2016
  • Figure 17: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2017 - 2022
  • Figure 18: Brazil: Diabetes Drug Industry Overview
  • Figure 19: Brazil: Diabetes Drug Market (in Million US$), 2009 - 2016
  • Figure 20: Brazil: Diabetes Drug Market Forecast (in Million US$), 2017 - 2022
  • Figure 21: Brazil: Diabetes Drug Market: SWOT Analysis
  • Figure 22: Brazil: Diabetes Drug Market: Value Chain Analysis
  • Figure 23: Brazil: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 24: Brazil: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2009 - 2016
  • Figure 25: Brazil: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2017 - 2022
  • Figure 26: Brazil: Oral Antidiabetics Market: (in Million US$), 2009 - 2016
  • Figure 27: Brazil: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2009 & 2016
  • Figure 28: Brazil: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 29: Brazil: Oral Antidiabetics Market: (in Million US$), 2017 - 2022
  • Figure 30: Brazil: Insulin Market, (in Million US$), 2009 - 2016
  • Figure 31: Brazil: Breakup of Insulin Market by Class (in %)
  • Figure 32: Brazil: Insulin Market: Sales Share of Key Players (in %)
  • Figure 33: Brazil: Insulin Market Forecast (in Million US$), 2017 - 2022

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2016 & 2035
  • Table 3: Brazil: Overweight & Obesity Statistics, 2010, 2016 & 2022
  • Table 4: Brazil: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
  • Table 5: Brazil: Total Prevalence & Number of Diabetes Patients*, 2009, 2016 & 2022
  • Table 6: Brazil (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 7: Brazil (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 8: Brazil (Male & Female): Total Prevalence & Number of Diabetes Patients, 2009, 2016 & 2022
  • Table 9: Brazil: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2009, 2016 & 2022
  • Table 10: Brazil: Diabetes Drug Market: Competitive Structure
Back to Top